New insulins for diabetes

Abstract

Diabetes treatments have come a long way, but continual efforts are needed to make the disease easier to manage and more affordable. Nearly half a million patients in the UK are prescribed insulin; however, despite insulin's increasing use, current licensed insulin products incur significant barriers, which have fuelled the need to develop novel insulins and drug delivery methods. This review will critically consider the role of new insulin preparations and delivery methods, such as Technosphere insulin, buccal spray insulin, very-long acting insulins, new insulin combinations, and ultra-fast acting insulin that aim to surmount these hurdles.